Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

MLA

Hudecek, J., et al. Application of a Risk-Management Framework for Integration of Stromal Tumor-Infiltrating Lymphocytes in Clinical Trials. Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5cc0eed7935fac67e7046bd597e941f6&authtype=sso&custid=ns315887.

APA

Hudecek, J., Voorwerk, L., van Seijen, M., Nederlof, I., de Maaker, M., van den Berg, J., van de Vijver, K. K., Sikorska, K., Adams, S., Demaria, S., Viale, G., Nielsen, T. O., Badve, S. S., Michiels, S., Symmans, W. F., Sotiriou, C., Rimm, D. L., Hewitt, S. M., Denkert, C., … Bago-Horvath, Z. (2020). Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.

Chicago

Hudecek, J., L. Voorwerk, M. van Seijen, I. Nederlof, M. de Maaker, J. van den Berg, K. K. van de Vijver, et al. 2020. “Application of a Risk-Management Framework for Integration of Stromal Tumor-Infiltrating Lymphocytes in Clinical Trials,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5cc0eed7935fac67e7046bd597e941f6&authtype=sso&custid=ns315887.